ACTAVIS SUBUTEX - AN OVERVIEW

The concomitant usage of buprenorphine and CYP3A4 inducers can decrease the plasma concentration of buprenorphine [see CLINICAL PHARMACOLOGY], probably causing diminished efficacy or onset of a withdrawal syndrome in sufferers who have made physical dependence to buprenorphine.Tummy or bowel blockage (including paralytic ileus)—Belbuca® really s